• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于注意缺陷多动障碍(ADHD)在不同发育阶段Wnt信号通路变化的研究。

An investigation on the alterations in Wnt signaling in ADHD across developmental stages.

作者信息

Walter Natalie Monet, Yde Ohki Cristine Marie, Rickli Michelle, Smigielski Lukasz, Walitza Susanne, Grünblatt Edna

机构信息

Department of Child and Adolescent Psychiatry and Psychotherapy, Translational Molecular Psychiatry, Psychiatric University Hospital Zurich, University of Zurich, Wagistrasse 12, 8952, Schlieren, Switzerland.

Biomedicine PhD Program, University of Zurich, Winterthurerstrasse 11, 8057, Zurich, Switzerland.

出版信息

Neurosci Appl. 2024 Apr 20;3:104070. doi: 10.1016/j.nsa.2024.104070. eCollection 2024.

DOI:10.1016/j.nsa.2024.104070
PMID:40656072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12244180/
Abstract

The canonical Wnt signaling pathway plays a vital role in the developmental processes of the Central Nervous System throughout both prenatal and postnatal stages, as well as in maintaining homeostasis during adulthood. Its complex intracellular cascade involves the participation of key proteins (i.e., GSK3β and β-catenin) to activate the transcription of Wnt target genes. These genes subsequently control processes like cell proliferation, maturation, and the determination of cell fate. Previous studies suggest that this pathway can also be associated with Attention-Deficit Hyperactivity Disorder (ADHD), a neurodevelopmental disorder with multifactorial etiology. This study aimed to clarify if and at what developmental stage the Wnt pathway is altered in ADHD. Accordingly, we carried out proteomic and functional assessments of the Wnt pathway using Western Blot and reporter assays, respectively. These assessments were performed at the induced pluripotent stem cell (iPSC), neural stem cell (NSC), and neuronal phases. IPSCs were generated from somatic cells retrieved from 5 controls and 5 patients diagnosed with ADHD. As opposed to the developmental stage of iPSCs, ADHD NSCs showed alterations in the protein expression of both GSK3β and β-catenin, suggesting increased Wnt activity in the ADHD group. Moreover, Wnt reporter assays confirmed higher Wnt activity in ADHD NSCs. Our molecular findings in NSCs correlated with genetic predisposition to ADHD and clinical traits displayed by their respective donors. In conclusion, these results suggest that a crucial cellular pathway is disrupted in patient-specific NSCs, potentially explaining the developmental deficits clinically exhibited by ADHD patients.

摘要

经典Wnt信号通路在中枢神经系统产前和产后阶段的发育过程中以及成年期维持体内平衡方面发挥着至关重要的作用。其复杂的细胞内级联反应涉及关键蛋白(即GSK3β和β-连环蛋白)的参与,以激活Wnt靶基因的转录。这些基因随后控制细胞增殖、成熟和细胞命运决定等过程。先前的研究表明,该通路也可能与注意力缺陷多动障碍(ADHD)有关,ADHD是一种病因多因素的神经发育障碍。本研究旨在阐明ADHD中Wnt通路是否以及在什么发育阶段发生改变。因此,我们分别使用蛋白质印迹法和报告基因检测对Wnt通路进行了蛋白质组学和功能评估。这些评估在诱导多能干细胞(iPSC)、神经干细胞(NSC)和神经元阶段进行。iPSC由从5名对照和5名被诊断为ADHD的患者中获取的体细胞生成。与iPSC的发育阶段不同,ADHD神经干细胞在GSK3β和β-连环蛋白的蛋白表达上均显示出改变,这表明ADHD组中Wnt活性增加。此外,Wnt报告基因检测证实ADHD神经干细胞中Wnt活性更高。我们在神经干细胞中的分子发现与ADHD的遗传易感性及其各自供体表现出的临床特征相关。总之,这些结果表明,在患者特异性神经干细胞中一条关键的细胞通路被破坏,这可能解释了ADHD患者临床上表现出的发育缺陷。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f86/12244180/4e2ac1296f9f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f86/12244180/eec37a983430/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f86/12244180/85508f63298a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f86/12244180/1d653cc50611/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f86/12244180/61f93767558a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f86/12244180/4e2ac1296f9f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f86/12244180/eec37a983430/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f86/12244180/85508f63298a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f86/12244180/1d653cc50611/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f86/12244180/61f93767558a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f86/12244180/4e2ac1296f9f/gr5.jpg

相似文献

1
An investigation on the alterations in Wnt signaling in ADHD across developmental stages.一项关于注意缺陷多动障碍(ADHD)在不同发育阶段Wnt信号通路变化的研究。
Neurosci Appl. 2024 Apr 20;3:104070. doi: 10.1016/j.nsa.2024.104070. eCollection 2024.
2
Short-Term Memory Impairment短期记忆障碍
3
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
4
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.兴奋剂和非兴奋剂药物治疗注意缺陷多动障碍和癫痫患者。
Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2.
5
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
6
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
7
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
8
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.安非他酮用于治疗成人注意力缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2.
9
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
10
-Related Tetrahydrobiopterin Deficiency (PTPSD)- 相关四氢生物蝶呤缺乏症(PTPSD)

引用本文的文献

1
Assessing the effects of methylphenidate in proliferation and Wnt activity of neuronal stem cells from attention deficit/hyperactivity disorder patients.评估哌甲酯对注意力缺陷多动障碍患者神经干细胞增殖及Wnt活性的影响。
J Neural Transm (Vienna). 2025 Jul 28. doi: 10.1007/s00702-025-02988-y.
2
The link between Wnt-related, stress-related, and circadian genes in the dermal fibroblasts of individuals with attention-deficit hyperactivity disorder.注意力缺陷多动障碍患者皮肤成纤维细胞中Wnt相关基因、应激相关基因和昼夜节律基因之间的联系。
J Neural Transm (Vienna). 2025 Jul 21. doi: 10.1007/s00702-025-02986-0.

本文引用的文献

1
Improving rigor and reproducibility in western blot experiments with the blotRig analysis.通过blotRig分析提高蛋白质印迹实验的严谨性和可重复性。
Sci Rep. 2024 Sep 17;14(1):21644. doi: 10.1038/s41598-024-70096-0.
2
The Role of Choline in Neurodevelopmental Disorders-A Narrative Review Focusing on ASC, ADHD and Dyslexia.胆碱在神经发育障碍中的作用——一篇聚焦于 ASC、ADHD 和诵读困难的叙述性综述。
Nutrients. 2023 Jun 25;15(13):2876. doi: 10.3390/nu15132876.
3
Protocol for a Wnt reporter assay to measure its activity in human neural stem cells derived from induced pluripotent stem cells.
用于测量诱导多能干细胞来源的人类神经干细胞中Wnt活性的Wnt报告基因检测方案。
Curr Res Neurobiol. 2023 Jun 17;5:100095. doi: 10.1016/j.crneur.2023.100095. eCollection 2023.
4
Generation of induced pluripotent stem cells from two ADHD patients and two healthy controls.从两名 ADHD 患者和两名健康对照中诱导生成多能干细胞。
Stem Cell Res. 2023 Jun;69:103084. doi: 10.1016/j.scr.2023.103084. Epub 2023 Mar 27.
5
From attention-deficit hyperactivity disorder to sporadic Alzheimer's disease-Wnt/mTOR pathways hypothesis.从注意力缺陷多动障碍到散发性阿尔茨海默病——Wnt/mTOR通路假说
Front Neurosci. 2023 Feb 16;17:1104985. doi: 10.3389/fnins.2023.1104985. eCollection 2023.
6
Growth rates of human induced pluripotent stem cells and neural stem cells from attention-deficit hyperactivity disorder patients: a preliminary study.注意缺陷多动障碍患者来源的诱导多能干细胞和神经干细胞的生长速度:一项初步研究。
J Neural Transm (Vienna). 2023 Mar;130(3):243-252. doi: 10.1007/s00702-023-02600-1. Epub 2023 Feb 17.
7
PRSet: Pathway-based polygenic risk score analyses and software.PRSet:基于通路的多基因风险评分分析及软件。
PLoS Genet. 2023 Feb 7;19(2):e1010624. doi: 10.1371/journal.pgen.1010624. eCollection 2023 Feb.
8
Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains.全基因组分析 ADHD 确定 27 个风险位点,细化遗传结构,并暗示几个认知领域。
Nat Genet. 2023 Feb;55(2):198-208. doi: 10.1038/s41588-022-01285-8. Epub 2023 Jan 26.
9
Hippocampal dentate gyri proteomics reveals Wnt signaling involvement in the behavioral impairment in the THRSP-overexpressing ADHD mouse model.海马齿状回蛋白质组学揭示 Wnt 信号通路参与 THRSP 过表达 ADHD 小鼠模型的行为障碍。
Commun Biol. 2023 Jan 16;6(1):55. doi: 10.1038/s42003-022-04387-5.
10
Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer's disease pathophysiology in cognitively unimpaired older adults.注意缺陷多动障碍的遗传风险预示着认知未受损的老年人会出现认知衰退和阿尔茨海默病病理生理过程的发展。
Mol Psychiatry. 2023 Mar;28(3):1248-1255. doi: 10.1038/s41380-022-01867-2. Epub 2022 Dec 8.